The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome
Open Access
- 1 October 2000
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 43 (10), 2349-2358
- https://doi.org/10.1002/1529-0131(200010)43:10<2349::aid-anr24>3.0.co;2-j
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytesArthritis & Rheumatism, 1998
- ENDOTHELIUM-DERIVED HAEMOSTATIC FACTORS AND THE ANTIPHOSPHOLIPID SYNDROMERheumatology, 1995
- Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosusAmerican Journal of Hematology, 1991
- The fibrinolytic response to venous occlusion and the natural anticoagulants in patients with antiphospholipid antibodies both with and without systemic lupus erythematosusBritish Journal of Haematology, 1991
- Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.BMJ, 1990
- ANTIPHOSPHOLIPID ANTIBODIESBritish Journal of Haematology, 1990
- Decreased fibrinolytic capacity and increased von Willebrand factor levels as indicators of endothelial cell dysfunction in patients with lupus anticoagulantClinical Rheumatology, 1989
- Plasminogen activation in plasma of patients with systemic lupus erythematosusRheumatology International, 1989
- ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATIONThe Lancet, 1981